Sorrento Tech, Inc.

Sorrento Tech, Inc. is a company specializing in advanced molecular testing solutions for food pathogen detection, leveraging innovative technologies to enhance food safety across various markets. Founded in 2009 in Warrenton, US, Sorrento Tech, Inc. focuses on food pathogen detection solutions.

The company has engaged in 5 deals, with its most recent deal occurring on July 16, 2014, during its IPO, where it raised USD 60 mn by selling 5 million shares at USD 12 each. The current CEO is Thomas Smith. Roka Bio Science specializes in advanced molecular testing solutions for food pathogen detection, primarily through its flagship Atlas® System. This system utilizes three core technologies—Target Capture, Transcription-Mediated Amplification, and Hybridization Protection Assay—to accurately identify foodborne pathogens such as E.

coli, Listeria, Salmonella, Campylobacter, and Legionella. By targeting ribosomal RNA (rRNA), these assays provide a highly sensitive and automated testing solution that significantly reduces enrichment times. Roka's products cater to a diverse client base, including laboratories and food safety organizations across various sectors like beef, dairy, produce, poultry, and ready-to-eat foods. The company operates in multiple geographical markets, including North America, Europe, and Asia, addressing the critical need for efficient and reliable food safety testing in these regions.

In 2016, Roka Bio Science reported a revenue of USD 7. 24 mn, while its EBITDA was USD -23. 65 mn for the same year. The company generates revenue primarily through the sale of its proprietary pathogen detection assays and the Atlas® System, which are designed for professional laboratories in the food safety sector.

Sorrento Tech, Inc. maintains a B2B transaction structure, facilitating direct sales to laboratories and food safety organizations. Clients typically engage in one-time purchases of assay kits, with the potential for ongoing contracts for product replenishment. Roka Bio Science plans to continue enhancing its product offerings by developing new assays and expanding the capabilities of the Atlas® System.

The company aims to enter additional markets across Europe and Asia by the end of 2025. The proceeds from its July 2014 IPO, where it raised USD 60 mn, will support these initiatives, facilitating research and development as well as market expansion efforts to solidify its position in the food safety sector.